ADMA Biologics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
465 State Rt 17, Ramsey, New Jersey, 074...Phone Number
(201) 478-5552Website
www.admabiologics.comRevenue
$509.9 MillionStock Symbol
ADMAIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About ADMA Biologics
Founded in 2004, ADMA Biologics is a commercial biopharmaceutical company that focuses on manufacturing, marketing, and developing products for immunodeficient patients at risk for infection. The company is headquartered in Ramsey, New Jersey.Explore more
ADMA Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ADMA Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ADMA Biologics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ADMA Biologics
Funding: Get notified immidiatlly once ADMA Biologics has new funding data
ADMA Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ADMA Biologics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ADMA Biologics launches new products
Check if ADMA Biologics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on ADMA Biologics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at ADMA Biologics
Find 2 more new buyers
Compare Similar Companies to ADMA Biologics
Compare insights from companies similar to ADMA Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ADMA Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ADMA Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ADMA Biologics.
ADMA Biologics financials insights
Gather financial insights about ADMA Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$15M
Corporate Investment
$5M
2015
Stock Offering
$10.3M
Debt
$21M
2016
Stock Offering
$14.1M
Debt
$4M
2017
Debt
$30M
Stock Offering
$39.1M
2018
Stock Offering
$40M
2019
Stock Offering
$51.8M
2020
Stock Offering
$82.3M
Debt
$100M
ADMA Biologics Tech Stack
A closer look at the technologies used by ADMA Biologics
Most Recent Scoops
Pain Point
Pain Point, Lawsuits, Legal Affairs
Person-Based
Lawsuits, Legal Affairs, Finance, Financial Transactions
Person-Based
Lawsuits, Legal Affairs, Revenue Operations
Person-Based
Earnings, Lawsuits, Legal Affairs, Finance
Person-Based
Audit, Board of Directors, Finance
ADMA Biologics News & Media
ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”), of the important August 10, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.NASDAQ: ADMA CLASS ACTION NOTICE: Berger Montague Encourages ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Inquire About a Securities Fraud Class Action
PHILADELPHIA, July 16, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA" or the "Company") on behalf of investors who purchased or acquired ADMA common stock during the period from...Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for ADMA Biologics (ADMA) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/10/2026SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)
ADMA Biologics Shareholders Between August 9, 2024 and March 25, 2026 - Contact Bernstein Liebhard For More Information Regarding Lawsuit
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ADMA Biologics
Sign Up For FreeTo access detailed company insights
Founded in 2004, ADMA Biologics is a commercial biopharmaceutical company that focuses on manufacturing, marketing, and developing products for immunodeficient patients at risk for infection. The company is headquartered in Ramsey, New Jersey.... Read More
